PASADENA, Calif., Sept. 10, 2024 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative mega campuses in AAA life science innovation cluster locations, today announced that Joel S. Marcus, the company's executive chairman and founder, is being honored with the inaugural Bisnow Life Sciences Icon & Influencer Award tomorrow afternoon, Wednesday, September 11, 2024. This prestigious award highlights Mr. Marcus and Alexandria's significant long-term contributions to and lasting impact on the life science real estate sector and broader life science industry. He will accept the award on his own behalf and that of Alexandria at Bisnow's International Life Sciences & Biotech Conference in Rockville, Maryland.
"We are thrilled to honor Joel, whose founding of and outstanding contributions to the life sciences real estate sector have earned him respect and admiration in this space," said Gregg Mayer, chief executive officer of Bisnow. "His perseverance and forward-thinking leadership, coupled with his commitment to innovation and ability to navigate challenging times, have not only resulted in a successful business but also helped mold the life science industry. We look forward to celebrating Joel and Alexandria's achievements at our conference tomorrow."
Mr. Marcus co-founded Alexandria in 1994, thus establishing and pioneering the life science real estate niche. Over the past three decades, he has led the company's transformation of life science real estate from a specialty niche into an important mainstream asset class. Alexandria's extraordinary positive impact on the life science industry is exemplified through its proven ability to evolve to meet and anticipate the industry's unique needs, its deep industry expertise that has led to longstanding strategic relationships with high-quality and diverse tenants, and its pivotal role in creating and growing life science ecosystems and clusters that catalyze innovative new medicines. Alexandria tenants have been responsible for 50% of the approximately 500 novel FDA-approved therapies since 2013.
"I am deeply honored to be the first recipient of this prestigious award from Bisnow. It reflects our entire team's dedication to our one-of-a-kind, mission-driven company and, importantly, to our world-class tenants," said Mr. Marcus. "We are proud to be at the vanguard and heart of the life science industry — the world's leader in the discovery and development of new medicines — and to create significant value well beyond physical real estate. With about 10,000 diseases known to humankind, over 90% of which still have no approved therapies or cures, now, more than ever, we need life science innovation to improve health and well-being and lessen human suffering, and we call on the government at all levels to champion and respect this cherished innovation industry. At Alexandria, we remain laser-focused on enhancing our mega campuses, which enable our life science tenants in their tireless pursuit of novel, more effective treatments and cures to address unmet medical needs while providing scale and flexibility for growth."
In addition to receiving the Bisnow Life Sciences Icon & Influencer Award, Mr. Marcus is the keynote speaker at the International Life Sciences & Biotech Conference tomorrow afternoon. Richard Bendis, president and chief executive officer of BioHealth Innovation, Inc., will join him for an insightful conversation on the state of the life science industry and how Alexandria built an irreplaceable Labspace® platform that continues to drive forward this vital $5 trillion secularly growing industry for the betterment of human health. Mr. Marcus will also discuss the company's strategic efforts to achieve and build upon the three outputs that renowned author and business strategist Jim Collins attributes to a great company: Superior Results, Distinctive Impact and Lasting Endurance.
About Alexandria Real Estate Equities, Inc.
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500® company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. As the pioneer of the life science real estate niche with our founding in 1994, Alexandria is the preeminent and longest-tenured owner, operator and developer of collaborative mega campuses in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle and New York City. As of June 30, 2024, Alexandria has a total market capitalization of $32.5 billion and an asset base in North America that includes 42.1 million RSF of operating properties and 5.3 million RSF of Class A/A+ properties undergoing construction and one committed near-term project expected to commence construction in the next two years. Alexandria has a longstanding and proven track record of developing Class A/A+ properties clustered in mega campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity and success. Alexandria also provides strategic capital to transformative life science companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns and greater long-term asset value. For more information on Alexandria, please visit www.are.com.
Forward-Looking Statements
This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, without limitation, statements regarding Alexandria's impact on the life science industry; its tenants' business and pursuit of novel treatment and cures, and human health and well-being; and its ability to meet and anticipate industry needs, maintain strategic relationships, and create and grow life science ecosystems and clusters that catalyze innovative new medicines. These forward-looking statements are based on Alexandria's present intent, beliefs or expectations, but forward-looking statements are not guaranteed to occur and may not occur. Actual results may differ materially from those contained in or implied by Alexandria's forward-looking statements as a result of a variety of factors, including, without limitation, the risks and uncertainties detailed in its filings with the Securities and Exchange Commission. All forward-looking statements are made as of the date of this press release, and Alexandria assumes no obligation to update this information. For more discussion relating to risks and uncertainties that could cause actual results to differ materially from those anticipated in Alexandria's forward-looking statements, and risks and uncertainties to Alexandria's business in general, please refer to Alexandria's filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and any subsequently filed quarterly reports on Form 10-Q.
CONTACT: Sara Kabakoff, Senior Vice President – Chief Content Officer, (626) 788-5578, This email address is being protected from spambots. You need JavaScript enabled to view it.
SOURCE Alexandria Real Estate Equities, Inc.
